BPC
AKBA icon

Banque Pictet & Cie’s Akebia Therapeutics AKBA Stock Holding History

Banque Pictet & Cie’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13,553
Closed -$300K – 472
2014
Q3 		$300K Sell
13,553
-389
-3% -$8.94K 0.01% 371
2014
Q2 		$387K Buy
+13,942
New +$336K 0.01% 309

Other funds holding AKBA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Banque Pictet & Cie's AKBA Position: Q4 2014 in Review

Banque Pictet & Cie sold out of Akebia Therapeutics (AKBA) in Q4 2014, closing a stake of 13,553 shares — an estimated $300K sold.

Banque Pictet & Cie first reported a position in AKBA in Q2 2014 and held it in 2 quarters. The position peaked at $387K in Q2 2014. 57 funds tracked by Wall St. Rank hold AKBA as of Q4 2014.

  • Banque Pictet & Cie reported no remaining Akebia Therapeutics position as of Q4 2014 after selling out during the quarter.
  • Banque Pictet & Cie sold 13,553 Akebia Therapeutics shares in Q4 2014, an estimated $300K.
  • Banque Pictet & Cie first reported a position in Akebia Therapeutics in Q2 2014 and held it in 2 quarters.
  • Banque Pictet & Cie's Akebia Therapeutics position peaked at $387K in Q2 2014.
  • 57 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2014.

Based on Banque Pictet & Cie's 13F filing for Q4 2014, filed 12 Feb 2015.